Variant report

Variant	rs11824695
Chromosome Location	chr11:36171128-36171129
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:36160393..36162372-chr11:36170521..36172813,2	K562	blood:
2	chr11:36044090..36046211-chr11:36170254..36173098,2	K562	blood:

Extended variants
information (count: 4 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs11033464	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv467791	chr11:36108497-36999385	Flanking Active TSS Weak transcription Strong transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
2	nsv554003	chr11:36108497-36999385	ZNF genes & repeats Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
3	nsv897225	chr11:36136912-36244190	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Strong transcription Genic enhancers Bivalent Enhancer Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:83 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:36157000-36171200	Weak transcription	Ovary	ovary
2	chr11:36163800-36176800	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr11:36164000-36171200	Weak transcription	Fetal Stomach	stomach
4	chr11:36164800-36174600	Weak transcription	Fetal Kidney	kidney
5	chr11:36165400-36171200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
6	chr11:36167600-36173600	Enhancers	HMEC	breast
7	chr11:36168000-36174600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr11:36169000-36175000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr11:36169000-36178200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr11:36169200-36174600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr11:36169400-36173200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr11:36169800-36173000	Enhancers	HSMM	muscle
13	chr11:36170000-36171200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
14	chr11:36170000-36171200	Enhancers	K562	blood
15	chr11:36170000-36171400	Enhancers	Placenta Amnion	Placenta Amnion
16	chr11:36170000-36173000	Enhancers	HSMMtube	muscle
17	chr11:36170000-36175400	Enhancers	NHDF-Ad	bronchial
18	chr11:36170200-36171200	Enhancers	Skeletal Muscle Male	skeletal muscle
19	chr11:36170200-36171600	Enhancers	Right Ventricle	heart
20	chr11:36170200-36171600	Enhancers	Spleen	Spleen
21	chr11:36170200-36171800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
22	chr11:36170200-36171800	Enhancers	Left Ventricle	heart
23	chr11:36170200-36172000	Enhancers	Primary hematopoietic stem cells short term culture	blood
24	chr11:36170200-36172000	Enhancers	Lung	lung
25	chr11:36170200-36172600	Enhancers	Breast Myoepithelial Primary Cells	Breast
26	chr11:36170200-36173000	Enhancers	NHLF	lung
27	chr11:36170200-36173200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
28	chr11:36170200-36173400	Enhancers	HUVEC	blood vessel
29	chr11:36170200-36173600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr11:36170200-36174400	Weak transcription	H9 Cell Line	embryonic stem cell
31	chr11:36170200-36175600	Enhancers	ES-I3 Cell Line	embryonic stem cell
32	chr11:36170400-36171600	Genic enhancers	Fetal Muscle Leg	muscle
33	chr11:36170400-36171800	Enhancers	Adipose Nuclei	Adipose
34	chr11:36170400-36172600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr11:36170400-36172800	Genic enhancers	Cortex derived primary cultured neurospheres	brain
36	chr11:36170400-36177000	Weak transcription	Brain Angular Gyrus	brain
37	chr11:36170600-36171200	Enhancers	Hela-S3	cervix
38	chr11:36170600-36172000	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr11:36170600-36172000	Enhancers	Fetal Intestine Large	intestine
40	chr11:36170600-36172200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr11:36170600-36172800	Enhancers	NH-A	brain
42	chr11:36170600-36173600	Enhancers	Psoas Muscle	Psoas
43	chr11:36170600-36175200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr11:36170800-36171200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr11:36170800-36171200	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr11:36170800-36171200	Flanking Active TSS	NHEK	skin
47	chr11:36170800-36171400	Enhancers	Monocytes-CD14+_RO01746	blood
48	chr11:36170800-36171600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr11:36170800-36172000	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr11:36170800-36172000	Enhancers	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links